Birch Hill Investment Advisors LLC Bristol Myers Squibb CO Transaction History

Birch Hill Investment Advisors LLC

$2.03 Billion
Q2 2024

A detailed history of Birch Hill Investment Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Birch Hill Investment Advisors LLC holds 7,980 shares of BMY stock, worth $406,341. This represents 0.02% of its overall portfolio holdings.

Number of Shares

7,980

Previous 8,831 9.64%

Holding current value

$406,341

Previous $478,000 30.75%

% of portfolio

0.02%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$40.25 - $52.99 $34,252 - $45,094	-851 Reduced 9.64%	7,980 $331,000
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $31,954 - $36,230	-666 Reduced 7.01%	8,831 $478,000
Q4 2023 Jan 29, 2024	SELL	$48.48 - $57.85 $431,181 - $514,517	-8,894 Reduced 48.36%	9,497 $487,000
Q3 2023 Oct 19, 2023	SELL	$57.89 - $64.73 $3,299 - $3,689	-57 Reduced 0.31%	18,391 $1.07 Million
Q1 2023 Apr 14, 2023	SELL	$65.71 - $74.53 $58,613 - $66,480	-892 Reduced 4.61%	18,448 $1.28 Million
Q4 2022 Jan 31, 2023	BUY	$68.48 - $81.09 $10,956 - $12,974	160 Added 0.83%	19,340 $1.39 Million
Q3 2022 Oct 19, 2022	SELL	$0.13 - $76.84 $6 - $3,842	-50 Reduced 0.26%	19,180 $1.36 Million
Q2 2022 Jul 13, 2022	SELL	$72.62 - $79.98 $3,631 - $3,999	-50 Reduced 0.26%	19,230 $1.48 Million
Q1 2022 Apr 08, 2022	BUY	$61.48 - $73.72 $98,368 - $117,952	1,600 Added 9.05%	19,280 $1.41 Million
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $148,769 - $173,430	-2,774 Reduced 13.56%	17,680 $1.1 Million
Q3 2021 Oct 25, 2021	SELL	$59.17 - $69.31 $59,170 - $69,310	-1,000 Reduced 4.66%	20,454 $1.21 Million
Q2 2021 Jul 22, 2021	SELL	$61.91 - $67.42 $19,192 - $20,900	-310 Reduced 1.42%	21,454 $1.43 Million
Q1 2021 Apr 26, 2021	SELL	$59.34 - $66.74 $365,059 - $410,584	-6,152 Reduced 22.04%	21,764 $1.37 Million
Q4 2020 Jan 27, 2021	SELL	$57.74 - $65.43 $103,932 - $117,774	-1,800 Reduced 6.06%	27,916 $1.73 Million
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $24,669 - $28,840	-450 Reduced 1.49%	29,716 $1.75 Million
Q1 2020 Apr 20, 2020	SELL	$46.4 - $67.43 $774,416 - $1.13 Million	-16,690 Reduced 35.62%	30,166 $1.68 Million
Q4 2019 Jan 17, 2020	BUY	$49.21 - $64.19 $1.86 Million - $2.43 Million	37,808 Added 417.86%	46,856 $3.01 Million
Q3 2019 Oct 16, 2019	SELL	$42.77 - $50.71 $21,385 - $25,355	-500 Reduced 5.24%	9,048 $459,000
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $430,805 - $513,682	9,548 New	9,548 $456,000
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $522,414 - $677,446	-10,714 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $49,671 - $56,025	-900 Reduced 7.75%	10,714 $665,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $40,424 - $50,384	-800 Reduced 6.44%	11,614 $643,000
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $11,864 - $13,658	-198 Reduced 1.57%	12,414 $785,000
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $71,799 - $82,862	1,300 Added 11.49%	12,612 $804,000
Q2 2017 Aug 11, 2017	BUY	N/A	11,312	11,312 $630,000

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Birch Hill Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Birch Hill Investment Advisors LLC with notifications on news.

Account

Birch Hill Investment Advisors LLC Bristol Myers Squibb CO Transaction History